Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
NCT ID:
NCT00565058
Pre Assignment Details:
Patients were enrolled in one of two treatment arms: "Pilot Arm" (Pilot PD Group) using delayed administration of GTI-2040, or a "Phase 2 Arm" (Phase II Group) using early administration of GTI-2040 with respect to High Dose Cytarabine (HiDAC).
Recruitment Details:
A total of 27 acute myeloid leukemia (AML) patients with either relapse (\> 6 months) after First complete remission (CR1) or refractory/early relapse CR1 duration \< 6 months were enrolled into the study from 6 sites. In total, 25 patients were treated with GTI-2040.
Study:
NCT00565058
Study Brief:
Results Section:
NCT00565058